Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAPPy Too trial for frequent episodic tension-type headache
ACTRN12617001323314Phase 4Terminated
- Sponsor
- The George Institute for Global Health
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of telmisartan, amlodipine and indapamide in tension-type headache (TTH) (2 arms), sponsored by The George Institute for Global Health. Primary endpoint: Change from baseline in mean monthly tension-type headache days. Started Apr 2018; status: terminated.
02
Drugs
telmisartanamlodipineindapamide
03
Conditions
tension-type headache (TTH)
Beyond the preview
Go deeper on ACTRN12617001323314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617001323314.